ELION THERAPEUTICS

Serial Number 98314270
730

Registration Progress

Application Filed
Dec 14, 2023
Under Examination
Apr 22, 2025
Approved for Publication
Feb 25, 2025
Published for Opposition
Feb 25, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 22, 2026 79 days

Trademark Image

ELION THERAPEUTICS

Basic Information

Serial Number
98314270
Filing Date
December 14, 2023
Published for Opposition
February 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Sep 24, 2025
Application
Pending
Classes
005

Rights Holder

ELION THERAPEUTICS, INC.

03
Address
345 PARK AVENUE SOUTH
SUITE 100
NEW YORK, NY 10010

Ownership History

Sfunga Therapeutics, Inc.

Original Applicant
03
New York, NY

ELION THERAPEUTICS, INC.

New Owner Before Publication #1
03
NEW YORK, NY

ELION THERAPEUTICS, INC.

Owner at Publication
03
NEW YORK, NY

Legal Representation

Attorney
J. Dickson Phillips III

USPTO Deadlines

Next Deadline
79 days remaining
NOA E-Mailed - SOU Required
Due Date
April 22, 2026
Extension Available
Until October 22, 2026

Application History

21 events
Date Code Type Description Documents
Sep 25, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 24, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 24, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 22, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 4, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 3, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 3, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jul 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 8, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 20, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-infective medications; Anti-fungal medications for administration by a healthcare professional in a healthcare setting to treat systemic fungal infections or invasive fungal disease

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"